Clinical Trial

A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

Name: A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors — clinical trial record (NCT07749703)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

an open-label, multicenter, Phase I study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics of SIM0532 in participants with advanced solid tumors. The study commences with a dose-escalation part (Part 1), followed by a dose-expansion part (Part 2).

Trial Details

NCT Number	NCT07749703
Lead Sponsor	Jiangsu Simcere Pharmaceutical Co., Ltd. Collaborators: Shanghai Xianwei Medical Technology Co., Ltd.
Conditions	Histologically or Cytologically Confirmed Advanced Solid Tumors
Enrollment	346 participants
Start Date	2026-03-31
Primary Completion	2028-06-30 (estimated)
Study Completion	2030-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-11